Latest News
|
7 June 2013
0 Likes 
Earlier this week, the US Food and Drug Administration (FDA) made a quiet but important announcement: Supplies of the drug Doxirubicin Liposomal Injection, a widely used cancer drug that has been
Read More...
Latest News
|
5 June 2013
1 Likes
An Untitled Letter sent by the US Food and Drug Administration (FDA) in May 2013 calls out Sigma-tau Pharmaceuticals for allegedly marketing its chemotherapy drug Oncaspar (pegaspargase) using a
Read More...
Regulatory Update
|
3 June 2013
0 Likes
Australia’s Therapeutic Goods Administration (TGA) has opened a consultation on proposed changes to the current regulatory framework for the advertising of therapeutic goods to the general public. The
Read More...
Latest News
|
31 May 2013
0 Likes
The US pharmaceutical industry has long been known to aggressively market its products, and not always in a scrupulous fashion. Now a new notice posted on the Federal Business Opportunities (FBO)
Read More...
Latest News
|
19 February 2013
2 Likes
The patient is male, middle-aged and has just suffered a massive heart attack. For now, he’s sedated, covered by blue cloth and being operated on by a female surgeon, with another attending surgeon
Read More...
Latest News
|
30 January 2013
1 Likes
The US Food and Drug Administration (FDA) has issued a rare multi-agency warning letter to a marketer of a product claiming to give patients protection against the influenza virus.The letter, sent on
Read More...
Latest News
|
4 December 2012
1 Likes
In a potentially landmark ruling, the US 2nd Circuit Court of Appeals has reversed a lower court's finding that a pharmaceutical sales representative was guilty of promoting off-label uses for certain
Read More...
Latest News
|
23 October 2012
0 Likes
The US Food and Drug Administration (FDA) has sent a warning letter to dietary supplement manufactured Advanced Nutritional Technology (AN) Inc. after regulators said an inspection found deficiencies
Read More...
Latest News
|
17 October 2012
0 Likes
Officials with Abbott Laboratories have announced the suspension of a controversial policy that has stoked controversy with critics who claim the company is buying favors from prescribing physicians
Read More...
Latest News
|
16 October 2012
0 Likes
The US Food and Drug Administration (FDA) has taken aim at another of the cosmetic industry's giants over the use of marketing claims reserved for approved pharmaceutical products—its fourth warning
Read More...